Regenerative Medicine Weekly Trend Line
May 21st, 2011
No comments
Shares of regenerative medicine stem cell companies were again …pummeled by depreciating markets by Friday, 5/20/11. Read more…
Archive
Posts Tagged ‘RENE.L’
Regenerative Medicine Weekly Trend Line
May 14th, 2011
No comments
Shares of regenerative medicine stem cell companies were pummeled hit by depreciating markets and profit taking by Friday, 5/13/11. Read more…
The Daily Look, 5/11/11, Mid-Week, Cause and Affect
May 11th, 2011
No comments
The 6 W’s: Who, what, where, when, why and what of it… Read more…
The RegMed Daily Dialogue, Mid-day, Monday, 5/9/11 – Sputtering and Struggling
May 9th, 2011
No comments
The 6 W’s: The … who, what, where, when, why and what of it. Read more…
Regenerative Medicine Weekly Trend Line
May 7th, 2011
No comments
Shares of regenerative medicine stem cell companies gyrated by low volumes and earnings by Friday, 5/6/11, after being excruciatingly pushed way down and some up during the week. Read more…
The Daily Look, 5/5/11, Waving the White Flag – Not Yet
May 5th, 2011
No comments
What happened to valuations in the regen med – stem cell market today ? Read more…
Categories: Stem Cell Research, The Daily Look, www. Scimitar Equity.com/blog
The Daily Dialogue, Mid-day, Thursday, 5/5/11
May 5th, 2011
No comments
What is driving the regenerative medicine – stem cell market mid-day … Read more…
The Daily Dialogue, Wednesday, 5/4/11
May 4th, 2011
No comments
What drove the regenerative medicine – stem cell market today … Read more…
Categories: Regenerative Medicine, Stem Cell Research, The Daily Dialogue
Regenerative Medicine Weekly Trend Line
May 1st, 2011
No comments
Shares of regenerative medicine stem cell companies were gyrated by low volumes by Friday, 4/29/11, after being pushed up and down during the week. Read more…
Regenerative Medicine Weekly Trend Line
April 17th, 2011
No comments
Shares of regenerative medicine companies gyrated through Friday, 4/15/11, after being pushed up and down during the week. Read more…
Henry W. McCusker
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.